Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash Flows from Operating Activities:
Net income	$ 2,138,663	$ 2,894,231
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	487,815	336,340
Stock compensation expense	489,748	961,589
Bad debt expense	295,050	230,700
(Increase) decrease in:
Trade receivables	(2,999,613)	(444,022)
Long-term receivables, prepaid and other assets	764,513	(1,722,362)
(Decrease) increase in:
Accounts payable	688,073	169,504
Accrued liabilities	(98,821)	92,281
Deferred revenue	9,548	(558,576)
Net cash provided by operating activities	1,774,976	1,959,685
Cash Flows from Investing Activities:
Capitalization of software costs	(111,241)	0
Purchase of property and equipment	(204,004)	(337,777)
Purchase of long-term investments	0	(3,150)
Net cash used in investing activities	(315,245)	(340,927)
Cash Flows from Financing Activities:
Proceeds from employee stock purchase plans	244,417	223,465
Proceeds from issuance of note payable	56,078	207,345
Net increase in lines of credit	380,000	130,432
Proceeds from exercise of options and warrants	666,903	121,625
Payments on notes payable and capital leases	(544,088)	(194,539)
Redemption of Series B-1 Preferred	(999,990)	0
Dividends paid	(488,897)	(7,932)
Net cash provided by (used in) financing activities	(685,577)	480,396
Net increase in cash and cash equivalents	774,154	2,099,154
Cash and cash equivalents at beginning of period	14,054,006	11,443,388
Cash and cash equivalents at end of period	14,828,160	13,542,542
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes	79,820	64,655
Cash paid for interest	136,500	31,004
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Common stock to pay accrued liabilities	971,127	770,858
Preferred stock to pay accrued liabilities	200,000	300,000
Dividends accrued on preferred stock	426,737	584,288
Dividends paid with preferred stock	$ 0	$ 557,071